Min Hospital has recently reached a cumulative total of 1,500 metabolic and bariatric surgeries, demonstrating extensive clinical expertise in the treatment of diabetes and metabolic diseases. The hospital attributes this achievement to precise patient selection and personalized surgical strategies that have led to stable treatment outcomes.
Metabolic and bariatric surgery at Min Hospital aims not only for weight reduction but also for the fundamental improvement of metabolic diseases, including diabetes. In clinical outcomes involving patients with early-stage diabetes, the hospital has reported a complete remission rate of 87 percent. These results clinically demonstrate that metabolic surgery can serve as a meaningful alternative beyond conventional medication-based treatment. A key factor behind these outcomes is the hospital’s precision-based treatment process, in which each patient’s disease stage and metabolic condition are carefully analyzed before selecting the most appropriate surgical method.
In particular, Min Hospital was the first in Korea to introduce and implement sleeve gastrectomy with ileal bypass (SASI), pioneering surgical treatment aimed specifically at diabetes management. The hospital currently performs a full range of metabolic and bariatric procedures, including sleeve gastrectomy, Roux-en-Y gastric bypass, duodenal bypass, jejunal bypass, and sleeve gastrectomy with ileal bypass. This capability reflects the institution’s ability to treat not only patients with obesity but also those with diabetes across a wide range of conditions.
Postoperative management is another key strength of the hospital. Min Hospital operates a 24-hour one-on-one intensive care system following surgery to help prevent complications and support faster recovery. In addition, it maintains university hospital–level laparoscopic operating rooms and anesthesia equipment optimized for metabolic surgery, ensuring a stable environment even for complex procedures. A fast-track system for patients traveling from outside the region further improves treatment accessibility and efficiency.
The hospital’s medical team has also been formally recognized for its contributions to the advancement of metabolic and bariatric surgery in Korea. The team received the Outstanding Paper Award from the Korean Society for Metabolic and Bariatric Surgery. Led by certified metabolic and bariatric surgeons Dr. Kim Jong-min and Dr. Sung Jong-je, Min Hospital continues to operate a structured clinical system as an officially certified metabolic and bariatric surgery center.
Dr. Kim Jong-min, Director of Min Hospital, stated that reaching 1,500 cases marks an important milestone. He added that the hospital plans to further advance its clinical system—including precise patient selection, personalized surgical approaches, and comprehensive postoperative management—to establish new standards in the treatment of obesity and diabetes.